Skip to main content

Opaleye Management Inc.

Position in URGN — UroGen Pharma Ltd.

CIK 1595855 Boston, MA

Position in URGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$25,711,400
+$19,424,934 QoQ
Shares Held
1,430,000
+432.7% QoQ
Ownership
2.94%
of shares outstanding
% of Portfolio
3.46%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Opaleye Management Inc. holds $427,835,777 across 44 Biotechnology names. URGN ranks #4 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 URGN
UroGen Pharma Ltd.
This page
1,430,000 $25,711,400

All Filings in URGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $25,711,400 1,430,000
2025-12-31 $6,286,466 268,423
2024-12-31 $2,343,000 220,000
2024-09-30 $5,132,070 404,100
2024-06-30 $6,913,360 412,000
2024-03-31 $4,050,000 270,000
2023-12-31 $4,800,000 320,000
2023-09-30 $4,483,200 320,000
2023-06-30 $5,899,500 570,000
2023-03-31 $4,666,200 505,000
2022-12-31 $4,334,378 488,656
2022-09-30 $3,307,200 397,500
2022-06-30 $1,954,707 238,670